Immunic to Participate in Key November Investor Conferences

Immunic, Inc., a biotechnology firm focused on developing oral therapies for neurologic diseases, will join several investor conferences this November. Notably, the company’s CEO Erik Lundgren and COO Jason Tardio will participate in fireside chats and individual meetings at the Guggenheim and Stifel Healthcare Conferences. These events will occur from November 9-12, providing a platform for Immunic to engage with investors in Boston and New York.

Additionally, Immunic’s management, alongside the Chief Business Officer Patrick Walsh, will conduct one-on-one meetings in London during the Jefferies Global Healthcare Conference from November 17-18. Beyond the financial discourse, Immunic will also host a Virtual R&D Day focused on progressive multiple sclerosis on November 5. This event will feature discussions on unmet needs in MS and innovative therapeutic approaches with experts like Jiwon Oh and Maria Pia Sormani.